CLINICAL_TRIALS ClinicalTrials.gov record update

Two-dose Primary Vaccination With Either GSK Biologicals' 10-valent Pneumococcal Vaccine (Synflorix™) or Pfizer's Prevenar 13™ or Both Vaccines Followed by a Booster Dose of Synflorix™

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01641133
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:17.452779+00:00
Published At: 2017-02-27T00:00:00+00:00
Record Updated At: 2021-03-02
Results Posted At: 2017-02-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Streptococcal", "Streptococcus Pneumoniae Vaccines"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-03-02"
protocolSection.identificationModule.nctId: "NCT01641133"
protocolSection.identificationModule.officialTitle: "Two-dose Primary Vaccination With Either GSK Biologicals\u0027 10-valent Pneumococcal Vaccine (Synflorix\u2122) or Pfizer\u0027s Prevenar 13\u2122 or Both Vaccines Followed by a Booster Dose of Synflorix\u2122"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-02-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.